NCT01438567View on ClinicalTrials.gov

A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

September 30, 2014

Conditions

PainConstipation

Interventions

DRUG

oxycodone/naloxone prolonged release (OXN PR) tablets

Drug: Oxycodone/naloxone prolonged release tablets Arms: OXN PR Dosage: 2x50/25mg daily or 2x60/30mg daily or 2x70/35mg daily or 2x80/40mg daily

DRUG

oxycodone prolonged release (OxyPR) tablets

Drug: Oxycodone prolonged release tablets Arms: OxyPR Dosage: 2x50mg daily or 2x60mg daily or 2x70mg daily or 2x80mg daily

Trial Locations (1)

Unknown

Ballygomartin Group Practice, Belfast

All Listed Sponsors

lead

Mundipharma Research GmbH & Co KG

INDUSTRY

NCT01438567 - A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy | Biotech Hunter | Biotech Hunter